S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA

Bibliographic Details
Main Authors: Chung Kok, Verity Saunders, Phuong Dang, Naranie Shanmuganathan, Deborah White, Susan Branford, David Yeung, Timothy Hughes
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000967516.90725.6e
_version_ 1797280874746609664
author Chung Kok
Verity Saunders
Phuong Dang
Naranie Shanmuganathan
Deborah White
Susan Branford
David Yeung
Timothy Hughes
author_facet Chung Kok
Verity Saunders
Phuong Dang
Naranie Shanmuganathan
Deborah White
Susan Branford
David Yeung
Timothy Hughes
author_sort Chung Kok
collection DOAJ
first_indexed 2024-03-07T16:47:32Z
format Article
id doaj.art-be62010580df43469fcc28aa45fbae47
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:47:32Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-be62010580df43469fcc28aa45fbae472024-03-03T06:24:58ZengWileyHemaSphere2572-92412023-08-017e907256e10.1097/01.HS9.0000967516.90725.6e202308003-00053S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIAChung Kok0Verity Saunders1Phuong Dang2Naranie Shanmuganathan3Deborah White4Susan Branford5David Yeung6Timothy Hughes71 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia2 The University of Adelaide, Adelaide Medical School, Adelaide, Australia1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australiahttp://journals.lww.com/10.1097/01.HS9.0000967516.90725.6e
spellingShingle Chung Kok
Verity Saunders
Phuong Dang
Naranie Shanmuganathan
Deborah White
Susan Branford
David Yeung
Timothy Hughes
S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA
HemaSphere
title S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA
title_full S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA
title_fullStr S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA
title_full_unstemmed S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA
title_short S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA
title_sort s151 combination of large spleen and low in vivo kinase inhibition is an early predictor of inferior molecular response and poor outcomes in chronic myeloid leukaemia
url http://journals.lww.com/10.1097/01.HS9.0000967516.90725.6e
work_keys_str_mv AT chungkok s151combinationoflargespleenandlowinvivokinaseinhibitionisanearlypredictorofinferiormolecularresponseandpooroutcomesinchronicmyeloidleukaemia
AT veritysaunders s151combinationoflargespleenandlowinvivokinaseinhibitionisanearlypredictorofinferiormolecularresponseandpooroutcomesinchronicmyeloidleukaemia
AT phuongdang s151combinationoflargespleenandlowinvivokinaseinhibitionisanearlypredictorofinferiormolecularresponseandpooroutcomesinchronicmyeloidleukaemia
AT naranieshanmuganathan s151combinationoflargespleenandlowinvivokinaseinhibitionisanearlypredictorofinferiormolecularresponseandpooroutcomesinchronicmyeloidleukaemia
AT deborahwhite s151combinationoflargespleenandlowinvivokinaseinhibitionisanearlypredictorofinferiormolecularresponseandpooroutcomesinchronicmyeloidleukaemia
AT susanbranford s151combinationoflargespleenandlowinvivokinaseinhibitionisanearlypredictorofinferiormolecularresponseandpooroutcomesinchronicmyeloidleukaemia
AT davidyeung s151combinationoflargespleenandlowinvivokinaseinhibitionisanearlypredictorofinferiormolecularresponseandpooroutcomesinchronicmyeloidleukaemia
AT timothyhughes s151combinationoflargespleenandlowinvivokinaseinhibitionisanearlypredictorofinferiormolecularresponseandpooroutcomesinchronicmyeloidleukaemia